Open Access<p>Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis</p>
Author(s) -
Chen Shu,
Xiaowei Yu,
Shiqi Cheng,
Jili Jing,
Cong Hu,
Bo Pang
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s274595
Subject(s) - trophoblast , flow cytometry , transfection , epithelial–mesenchymal transition , apoptosis , cell , mesenchymal stem cell , cancer research , microrna , chemistry , microbiology and biotechnology , downregulation and upregulation , cell culture , biology , placenta , fetus , gene , biochemistry , pregnancy , genetics
Ectopic pregnancy (EP) is an ectopic embryo implantation occurred outside the uterine cavity. Nowadays, more attention have garnered in fast and effective treatment with less side effects. Pristimerin is known as the clinical application for anti-cancer, and the effect on EP therapy is still unclear.